Published in Clin Transplant on April 04, 2011
Hepatocellular carcinoma: cost-effectiveness of screening. A systematic review. Risk Manag Healthc Policy (2012) 1.02
Ultrasound elastography for fibrosis surveillance is cost effective in patients with chronic hepatitis C virus in the UK. Dig Dis Sci (2013) 0.88
Optimal tailored screening protocol after living donor liver transplantation for hepatocellular carcinoma. J Korean Med Sci (2014) 0.78
De novo Hepatocellular Carcinoma after Liver Transplantation. J Clin Transl Hepatol (2015) 0.75
Therapeutic Hypothermia in Deceased Organ Donors and Kidney-Graft Function. N Engl J Med (2015) 5.12
Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology (2008) 4.26
Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria. Liver Transpl (2014) 3.11
Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology (2005) 2.63
A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation. Liver Transpl (2005) 2.56
Identification of liver transplant candidates with hepatocellular carcinoma and a very low dropout risk: implications for the current organ allocation policy. Liver Transpl (2013) 2.53
Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl (2002) 2.28
Improving liver allocation: MELD and PELD. Am J Transplant (2004) 2.14
Factors associated with outcomes and response to therapy in patients with infiltrative hepatocellular carcinoma. Clin Gastroenterol Hepatol (2013) 2.11
Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl (2002) 2.03
The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma. Am J Transplant (2005) 1.90
Sirolimus prolongs recovery from delayed graft function after cadaveric renal transplantation. Am J Transplant (2003) 1.65
Predictors associated with terminal renal function in deceased organ donors in the intensive care unit. Anesthesiology (2009) 1.60
Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study. Transplantation (2003) 1.54
Time to transplantation as a predictor of hepatocellular carcinoma recurrence after liver transplantation. Liver Transpl (2014) 1.54
Safety of cardiac catheterization in patients with end-stage liver disease awaiting liver transplantation. Am J Cardiol (2009) 1.53
Hepatic steatosis at 1 year is an additional predictor of subsequent fibrosis severity in liver transplant recipients with recurrent hepatitis C virus. Liver Transpl (2011) 1.52
Outcomes with split liver transplantation in 106 recipients: the University of California, San Francisco, experience from 1993 to 2010. Arch Surg (2011) 1.51
Use of CT cholangiography to evaluate the biliary tract after liver transplantation: initial experience. Liver Transpl (2004) 1.50
Liver transplantation for hepatocellular carcinoma. Ann Surg Oncol (2008) 1.50
Expanding the donor pool: can the Spanish model work in the United States? Am J Transplant (2003) 1.48
Factors influencing liver transplant length of stay at two large-volume transplant centers. Liver Transpl (2009) 1.48
Selection criteria for liver transplantation in patients with hepatocellular carcinoma: beyond tumor size and number? Liver Transpl (2006) 1.46
Calcineurin inhibitor-free mycophenolate mofetil/sirolimus maintenance in liver transplantation: the randomized spare-the-nephron trial. Liver Transpl (2013) 1.46
Trends over a decade of pediatric liver transplantation in the United States. Liver Transpl (2006) 1.45
Report of the Crystal City meeting to maximize the use of organs recovered from the cadaver donor. Am J Transplant (2002) 1.44
Offer patterns of nationally placed livers by donation service area. Liver Transpl (2013) 1.42
Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants. JAMA (2012) 1.33
A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy. Liver Transpl (2003) 1.25
Accuracy of plain abdominal radiographs in the detection of retained surgical needles in the peritoneal cavity. Ann Surg (2008) 1.24
Presentation of reversible posterior leukoencephalopathy syndrome in patients on calcineurin inhibitors. Clin Neurol Neurosurg (2010) 1.22
Acute kidney injury during liver transplantation as determined by neutrophil gelatinase-associated lipocalin. Liver Transpl (2009) 1.20
Summary report of a national conference: Evolving concepts in liver allocation in the MELD and PELD era. December 8, 2003, Washington, DC, USA. Liver Transpl (2004) 1.19
Imaging predictors of the response to transarterial chemoembolization in patients with hepatocellular carcinoma: a radiological-pathological correlation. Liver Transpl (2012) 1.18
Metabolic profiling of livers and blood from obese Zucker rats. J Hepatol (2005) 1.16
New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection. Liver Transpl (2004) 1.11
Left lobe adult-to-adult living donor liver transplantation: small grafts and hemiportocaval shunts in the prevention of small-for-size syndrome. Liver Transpl (2010) 1.11
Laparoscopic procurement of kidneys with multiple renal arteries is associated with increased ureteral complications in the recipient. Am J Transplant (2005) 1.08
Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma. Liver Transpl (2011) 1.08
Applicability, tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation. Am J Transplant (2005) 1.06
Long-term renal function and cardiovascular disease risk in obese kidney donors. Clin J Am Soc Nephrol (2009) 1.04
Validating posttransplant hepatocellular carcinoma recurrence data in the United Network for Organ Sharing database. Liver Transpl (2013) 1.02
Liver transplantation for hepatocellular carcinoma: lessons from the first year under the Model of End-Stage Liver Disease (MELD) organ allocation policy. Liver Transpl (2004) 1.01
De novo malignancies following liver transplantation: a case-control study with long-term follow-up. Clin Transplant (2006) 0.99
Risk factors for liver transplant waitlist dropout in patients with hepatocellular carcinoma. Clin Transplant (2012) 0.99
Biliary tract depiction in living potential liver donors: comparison of conventional MR, mangafodipir trisodium-enhanced excretory MR, and multi-detector row CT cholangiography--initial experience. Radiology (2004) 0.98
Moving past "One size (and number) fits all" in the selection of candidates with hepatocellular carcinoma for liver transplantation. Liver Transpl (2013) 0.98
Outcomes after liver transplantation for patients with hepatocellular carcinoma and a low risk of dropout from the transplant waiting list. Liver Transpl (2014) 0.97
Prediction of survival after liver retransplantation for late graft failure based on preoperative prognostic scores. Hepatology (2004) 0.96
Use of rifabutin for the treatment of a latent tuberculosis infection in a patient after solid organ transplantation. Liver Transpl (2013) 0.95
Use of living donor liver transplantation varies with the availability of deceased donor liver transplantation. Liver Transpl (2012) 0.93
Increased severity of renal ischemia-reperfusion injury with venous clamping compared to arterial clamping in a rat model. Surgery (2007) 0.92
Hepatitis B virus quasispecies in hepatic and extrahepatic viral reservoirs in liver transplant recipients on prophylactic therapy. Liver Transpl (2011) 0.92
Projected future increase in aging hepatitis C virus-infected liver transplant candidates: a potential effect of hepatocellular carcinoma. Liver Transpl (2012) 0.91
Concordance of second-order portal venous and biliary tract anatomies on MDCT angiography and MDCT cholangiography. AJR Am J Roentgenol (2005) 0.91
Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus-related cirrhosis. Clin Gastroenterol Hepatol (2005) 0.91
Living donor candidates for right hepatic lobe transplantation: evaluation at CT cholangiography--initial experience. Radiology (2005) 0.89
Current approach to down-staging of hepatocellular carcinoma prior to liver transplantation. Curr Opin Organ Transplant (2008) 0.89
Warm ischemia-induced alterations in oxidative and inflammatory proteins in hepatic Kupffer cells in rats. Mol Cell Proteomics (2006) 0.88
Frequent salvage of ruptured renal allografts: a large single center experience. Clin Transplant (2003) 0.88
Intraoperative hemodynamics and liver function in adult-to-adult living liver donors. Liver Transpl (2002) 0.88
Predicting biliary complications in right lobe liver transplant recipients according to distance between donor's bile duct and corresponding hepatic artery. Radiology (2007) 0.87
Donor health assessment after living-donor liver transplantation. Ann Surg (2002) 0.87
Central venous pressure monitoring during living right donor hepatectomy. Liver Transpl (2007) 0.87
Mild hypothermia provides significant protection against ischemia/reperfusion injury in livers of obese and lean rats. Ann Surg (2005) 0.87
Morbidity and mortality following transarterial liver chemoembolization in patients with hepatocellular carcinoma and synthetic hepatic dysfunction. Liver Transpl (2012) 0.86
The Evolution of Organ Allocation for Liver Transplantation: Tackling Geographic Disparity Through Broader Sharing. Ann Surg (2015) 0.86
Ischemic preconditioning improves energy state and transplantation survival in obese Zucker rat livers. Anesth Analg (2005) 0.85
CD69 expression on peripheral CD8 T cells correlates with acute rejection in renal transplant recipients. Transplantation (2003) 0.85
Posttransplant metabolic syndrome in children and adolescents after liver transplantation: a systematic review. Liver Transpl (2012) 0.84
Long-term outcome of human leukocyte antigen mismatching in liver transplantation: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Hepatology (2008) 0.84
Laparoscopic right donor nephrectomy: a large single-center experience. Transplantation (2004) 0.83
The use of stents for duct-to-duct anastomoses of biliary reconstruction in orthotopic liver transplantation. Hepatogastroenterology (2005) 0.82
Ischemia-reperfusion injury is more severe in older versus young rat livers. J Surg Res (2006) 0.80
Response to letter to the editors. Liver Transpl (2014) 0.80
Restricting liver transplant recipients to younger donors does not increase the wait-list time or the dropout rate: the hepatitis C experience. Liver Transpl (2014) 0.80
Expanded criteria donor kidney allocation: marked decrease in cold ischemia and delayed graft function at a single center. Am J Transplant (2005) 0.79
Long-term histological effects of preemptive antiviral therapy in liver transplant recipients with hepatitis C virus infection. Liver Transpl (2008) 0.79
Experience with laparoscopic donor nephrectomy among more than 1000 cases: low complication rates, despite more challenging cases. Arch Surg (2011) 0.79
Targeted gene therapy with CD40Ig to induce long-term acceptance of liver allografts. Surgery (2002) 0.78
Determinants of second-order bile duct visualization at CT cholangiography in potential living liver donors. AJR Am J Roentgenol (2013) 0.78
CT cholangiography in potential liver donors: effect of premedication with intravenous morphine on biliary caliber and visualization. Radiology (2008) 0.78
Outcomes of surgical repair of bile leaks and strictures after adult-to-adult living donor liver transplant. Clin Transplant (2010) 0.78
Implications of discordant findings between hepatic angiography and cross-sectional imaging in transplant candidates with hepatocellular carcinoma. Liver Transpl (2015) 0.78
Applying expanded criteria to liver transplantation for hepatocellular carcinoma: too much too soon, or is now the time? Liver Transpl (2004) 0.78
Rex shunt preoperative imaging: diagnostic capability of imaging modalities. PLoS One (2011) 0.78
Mild hypothermia protects obese rats from fulminant hepatic necrosis induced by ischemia-reperfusion. Surgery (2006) 0.77
Ethical issues in split versus whole liver transplantation. Am J Transplant (2004) 0.77
Management of hepatitis C-infected liver transplant recipients at large North American centres: changes in recent years. Clin Transplant (2006) 0.77
De novo non-alcoholic fatty liver disease following orthotopic liver transplantation. Am J Transplant (2003) 0.77
Wait Time of < 6 and > 18 Months Predicts Hepatocellular Carcinoma Recurrence after Liver Transplantation: Proposing a Wait Time "Sweet Spot". Transplantation (2017) 0.76
Ex vivo split-liver transplantation: the true right/left split. HPB (Oxford) (2013) 0.76
Potential role of the donor in hepatocellular carcinoma recurrence after liver transplantation. Liver Transpl (2015) 0.76
High incidence of recurrence and hematologic events following liver transplantation for Budd-Chiari syndrome. Clin Transplant (2005) 0.76